EUVIMEDEUVIMED entdecken
Crossref

The use of midostaurin in the treatment of advanced systemic mastocytosis

Marek Hus, Aneta Szudy-Szczyrek, Justyna Kozińska, Oliwia Bachanek-Mitura

Hematology in Clinical Practice · 2021

DOI: 10.5603/hcp.2021.0010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematology in Clinical Practice, 2021. Verfasst von Marek Hus und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hus, M., Szudy-Szczyrek, A., Kozińska, J., & Bachanek-Mitura, O. (2021). The use of midostaurin in the treatment of advanced systemic mastocytosis. Hematology in Clinical Practice. https://doi.org/10.5603/hcp.2021.0010

Vancouver

Hus M, Szudy-Szczyrek A, Kozińska J, Bachanek-Mitura O. The use of midostaurin in the treatment of advanced systemic mastocytosis. Hematology in Clinical Practice. 2021. doi:10.5603/hcp.2021.0010

BibTeX
@article{Hus2021,
  author = {Hus, Marek and Szudy-Szczyrek, Aneta and Kozińska, Justyna and Bachanek-Mitura, Oliwia},
  title = {The use of midostaurin in the treatment of advanced systemic mastocytosis},
  journal = {Hematology in Clinical Practice},
  year = {2021},
  doi = {10.5603/hcp.2021.0010}
}
Kostenlos starten →